Literature DB >> 3146615

Haemostasis contact system and fibrinolysis in hereditary angioedema (C1-inhibitor deficiency).

M Cugno1, L Bergamaschini, L Uziel, M Cicardi, A Agostoni, A F Jie, C Kluft.   

Abstract

Factors of the classical complement pathway, the contact system and fibrinolysis were evaluated both with functional and immunochemical methods, in patients with inherited deficiency of C1-inhibitor. Evaluations were performed under basal conditions, during acute attacks and during prophylaxis with low doses of anabolic steroids. Patients in the basal state showed no significant abnormalities of any of the parameters that we investigated. During acute attacks a slightly reduced prekallikrein concentration was registered. During treatment with low doses of danazol and stanozolol, protein C and plasminogen were found to be increased. Our data suggest that C1-inhibitor deficiency per se does not lead to a derangement of the fibrinolysis and coagulation contact system, and that the kinin system may be involved during acute attacks of angioedema.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3146615     DOI: 10.1515/cclm.1988.26.7.423

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  5 in total

1.  Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency.

Authors:  M van Geffen; M Cugno; P Lap; A Loof; M Cicardi; W van Heerde
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

2.  Plasma levels of C1- inhibitor complexes and cleaved C1- inhibitor in patients with hereditary angioneurotic edema.

Authors:  M Cugno; J Nuijens; E Hack; A Eerenberg; D Frangi; A Agostoni; M Cicardi
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 3.  Coagulation and Skin Autoimmunity.

Authors:  Massimo Cugno; Alessandro Borghi; Simone Garcovich; Angelo Valerio Marzano
Journal:  Front Immunol       Date:  2019-06-20       Impact factor: 7.561

Review 4.  Bradykinin: Inflammatory Product of the Coagulation System.

Authors:  Zonne Hofman; Steven de Maat; C Erik Hack; Coen Maas
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

5.  Pharmacological suppression of the kallikrein kinin system with KVD900: An orally available plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema.

Authors:  Edward J Duckworth; Nivetha Murugesan; Lily Li; Louise J Rushbrooke; Daniel K Lee; Gian Marco De Donatis; Andreas Maetzel; Christopher M Yea; Sally L Hampton; Edward P Feener
Journal:  Clin Exp Allergy       Date:  2022-03-20       Impact factor: 5.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.